‘The New Normal’ AI toolset coming to a public place near you?

A company with a name that sounds like a book title has formed to beat back COVID and future health crises by tapping the powers of AI.

The New Normal: AI Solutions for Post-Pandemic America announced its launch from San Francisco July 31, saying it’s got deployment-ready AI tools for helping with social distancing, crowdsize control, facemask compliance and fever detection.

“We see AI as an essential part of maintaining public health in post-pandemic America,” says CEO Steven Piekarczyk, “which is why we’re focusing our energy and resources on making this technology available as widely as possible.”

The company has posted a video showing its ideas in action.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.